Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss may signal metabolic problems and increased risk of heart disease, suggesting people with hair loss should be checked for these issues.

People with more than 11 skin tags, especially on the thigh, neck, or armpit, may have a higher chance of metabolic syndrome.

Women with PCOS often have metabolic issues like insulin resistance and a higher risk of diabetes and abnormal lipid levels.

Women with PCOS often have insulin resistance, abnormal lipid levels, and a higher risk of diabetes and heart disease; lifestyle changes and medication like metformin can help manage these risks.

The study suggests that being overweight or obese, not PCOS itself, is strongly linked to insulin resistance.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

Older obese women with PCOS have higher cardiovascular and metabolic risks despite lower androgen levels.

Losing weight and eating better are key to managing metabolic syndrome and its related conditions.

Polycystic ovary syndrome is a complex condition that affects women's mental, reproductive, and metabolic health throughout their lives.

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.

High afamin levels are linked to metabolic syndrome and may predict its development in women with insulin resistance.

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

Rosiglitazone may be better than metformin for insulin resistance in PCOS, but more research is needed on certain biomarkers.

Metabolic syndrome in kids and teens is linked to obesity and increases diabetes and heart disease risk; early lifestyle changes are crucial for management.

No clear link between hair loss and metabolic syndrome, but some differences in blood pressure and glucose levels.

Many infertile women with PCOS in Central Vietnam have metabolic or insulin resistance syndrome, with obesity and older age increasing the risk.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

Irregular menstrual cycles in teenagers are linked to a higher risk of polycystic ovary syndrome and metabolic syndrome.

Obese Hispanic women with PCOS are at higher risk for metabolic problems than non-Hispanic white women.

New guidelines stress early diagnosis and lifestyle changes to manage metabolic syndrome and prevent complications.

Chromium supplements don't help with weight loss or improve hormone and metabolism issues in people with polycystic ovary syndrome.

Metformin effectively improves metabolic symptoms in women with PCOS, while alfacalcidiol does not have a significant impact.

Managing metabolic syndrome needs both lifestyle changes and medical treatments.

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

Metformin has limited effectiveness for improving PCOS symptoms and lacks clear benefits, needing more research to confirm its efficacy.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

Metformin combined with lifestyle changes improves insulin resistance and reduces testosterone levels in women with PCOS more than lifestyle changes alone.

Type 2 diabetes in youth is increasing, with high treatment failure rates and more severe than Type 1; certain drugs can lower lipid levels effectively with varying side effects, and apples may benefit heart health like statins but with fewer side effects.

Anovulatory PCOS patients are younger with longer cycles and higher blood pressure and hormone levels.